Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000520815 | SCV000619692 | uncertain significance | not provided | 2017-07-31 | criteria provided, single submitter | clinical testing | The c.196 A>C (R66=) variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The variant is observed in 1/11492 (0.0087%) alleles from individuals of Latino background in the ExAC dataset (Lek et al., 2016). c.196 A>C is a synonymous variant, and in silico analysis predicts this variant likely does not alter gene splicing. However, this variant occurs at a position that is conserved across species. In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Invitae | RCV002060276 | SCV002337665 | likely benign | Legius syndrome | 2022-09-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003159678 | SCV003868993 | likely benign | Cardiovascular phenotype | 2023-01-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |